Assuntos
Carcinoma de Células Escamosas/patologia , Papillomaviridae/classificação , Infecções por Papillomavirus/patologia , Lesões Pré-Cancerosas/patologia , Infecções Tumorais por Vírus/patologia , Neoplasias Vulvares/patologia , Adulto , Distribuição por Idade , Idoso , Biópsia por Agulha , Carcinoma de Células Escamosas/epidemiologia , Carcinoma de Células Escamosas/virologia , Estudos de Coortes , Bases de Dados Factuais , Feminino , Humanos , Imuno-Histoquímica , Incidência , Pessoa de Meia-Idade , Invasividade Neoplásica/patologia , Teste de Papanicolaou , Infecções por Papillomavirus/epidemiologia , Prognóstico , Medição de Risco , Infecções Tumorais por Vírus/epidemiologia , Neoplasias Vulvares/epidemiologia , Neoplasias Vulvares/virologiaAssuntos
Púrpura/diagnóstico , Sapatos , Vasculite/diagnóstico , Exercício Físico , Feminino , Técnica Direta de Fluorescência para Anticorpo , Pé , Glucocorticoides/administração & dosagem , Glucocorticoides/uso terapêutico , Humanos , Púrpura/tratamento farmacológico , Púrpura/etiologia , Triancinolona/administração & dosagem , Triancinolona/uso terapêutico , Vasculite/etiologia , Adulto JovemRESUMO
IMPORTANCE: Worldwide, the nonnucleoside reverse transcriptase inhibitors (NNRTIs) efavirenz and nevirapine are commonly used in first-line antiretroviral regimens in both adults and children with human immunodeficiency virus (HIV) infection. Data on the comparative effectiveness of these medications in children are limited. OBJECTIVE: To investigate whether virological failure is more likely among children who initiated 1 or the other NNRTI-based HIV treatment. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of children (aged 3-16 years) who initiated efavirenz-based (n = 421) or nevirapine-based (n = 383) treatment between April 2002 and January 2011 at a large pediatric HIV care setting in Botswana. MAIN OUTCOMES AND MEASURES: The primary outcome was time from initiation of therapy to virological failure. Virological failure was defined as lack of plasma HIV RNA suppression to less than 400 copies/mL by 6 months or confirmed HIV RNA of 400 copies/mL or greater after suppression. Cox proportional hazards regression analysis compared time to virological failure by regimen. Multivariable Cox regression controlled for age, sex, baseline immunologic category, baseline clinical category, baseline viral load, nutritional status, NRTIs used, receipt of single-dose nevirapine, and treatment for tuberculosis. RESULTS: With a median follow-up time of 69 months (range, 6-112 months; interquartile range, 23-87 months), 57 children (13.5%; 95% CI, 10.4%-17.2%) initiating treatment with efavirenz and 101 children (26.4%; 95% CI, 22.0%-31.1%) initiating treatment with nevirapine had virological failure. There were 11 children (2.6%; 95% CI, 1.3%-4.6%) receiving efavirenz and 20 children (5.2%; 95% CI, 3.2%-7.9%) receiving nevirapine who never achieved virological suppression. The Cox proportional hazard ratio for the combined virological failure end point was 2.0 (95% CI, 1.4-2.7; log rank P < .001, favoring efavirenz). None of the measured covariates affected the estimated hazard ratio in the multivariable analyses. CONCLUSIONS AND RELEVANCE: Among children aged 3 to 16 years infected with HIV and treated at a clinic in Botswana, the use of efavirenz compared with nevirapine as initial antiretroviral treatment was associated with less virological failure. These findings may warrant additional research evaluating the use of efavirenz and nevirapine for pediatric patients.
Assuntos
Antirretrovirais/uso terapêutico , Benzoxazinas/uso terapêutico , Infecções por HIV/tratamento farmacológico , Nevirapina/uso terapêutico , RNA Viral/sangue , Adolescente , Alcinos , Botsuana , Criança , Pré-Escolar , Estudos de Coortes , Ciclopropanos , Quimioterapia Combinada , Feminino , Humanos , Masculino , Análise de Regressão , Estudos Retrospectivos , Falha de Tratamento , Carga ViralAssuntos
Histiocitoma Fibroso Benigno/diagnóstico , Neoplasias Cutâneas/diagnóstico , Idoso de 80 Anos ou mais , Derme/patologia , Células Endoteliais/metabolismo , Epiderme/patologia , Feminino , Histiocitoma Fibroso Benigno/patologia , Humanos , Neoplasias Cutâneas/patologia , Células Estromais/metabolismo , Coxa da PernaRESUMO
The purpose of this review is to systematically appraise the peer-reviewed literature about clustered forms of psychopathology and to present a framework that can be useful for studying comorbid psychiatric disorders. The review focuses on four of the most prevalent types of mental health problems: anxiety, depression, conduct disorder, and substance abuse. The authors summarize existing empirical research on the distribution of concurrent and sequential comorbidity in children and adolescents and in adults, and they review existing knowledge about exogenous risk factors that influence comorbidity. The authors include articles that used a longitudinal study design and used psychiatric definitions of the disorders. A total of 58 articles met the inclusion criteria and were assessed. Current evidence demonstrates a reciprocal, sequential relation between most comorbid pairs, although the mechanisms that mediate such links remain to be explained. Methodological concerns include the inconsistency of measurement of the disorders across studies, small sample sizes, and restricted follow-up times. Given the significant mental health burden placed by comorbid disorders, and their high prevalence across populations, research on the key risk factors for clustering of psychopathology is needed.